These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27152243)

  • 1. Histone modifiers and marks define heterogeneous groups of colorectal carcinomas and affect responses to HDAC inhibitors in vitro.
    Lutz L; Fitzner IC; Ahrens T; Geißler AL; Makowiec F; Hopt UT; Bogatyreva L; Hauschke D; Werner M; Lassmann S
    Am J Cancer Res; 2016; 6(3):664-76. PubMed ID: 27152243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
    Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
    Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo.
    Weichert W; Röske A; Niesporek S; Noske A; Buckendahl AC; Dietel M; Gekeler V; Boehm M; Beckers T; Denkert C
    Clin Cancer Res; 2008 Mar; 14(6):1669-77. PubMed ID: 18347167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A toolbox for class I HDACs reveals isoform specific roles in gene regulation and protein acetylation.
    Hess L; Moos V; Lauber AA; Reiter W; Schuster M; Hartl N; Lackner D; Boenke T; Koren A; Guzzardo PM; Gundacker B; Riegler A; Vician P; Miccolo C; Leiter S; Chandrasekharan MB; Vcelkova T; Tanzer A; Jun JQ; Bradner J; Brosch G; Hartl M; Bock C; Bürckstümmer T; Kubicek S; Chiocca S; Bhaskara S; Seiser C
    PLoS Genet; 2022 Aug; 18(8):e1010376. PubMed ID: 35994477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer.
    Alzoubi S; Brody L; Rahman S; Mahul-Mellier AL; Mercado N; Ito K; El-Bahrawy M; Silver A; Boobis A; Bell JD; Hajji N
    Oncotarget; 2016 Jul; 7(28):44505-44521. PubMed ID: 27283986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin.
    Hayashi A; Horiuchi A; Kikuchi N; Hayashi T; Fuseya C; Suzuki A; Konishi I; Shiozawa T
    Int J Cancer; 2010 Sep; 127(6):1332-46. PubMed ID: 20049841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDAC3 overexpression and colon cancer cell proliferation and differentiation.
    Spurling CC; Godman CA; Noonan EJ; Rasmussen TP; Rosenberg DW; Giardina C
    Mol Carcinog; 2008 Feb; 47(2):137-47. PubMed ID: 17849419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer--overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression.
    Müller BM; Jana L; Kasajima A; Lehmann A; Prinzler J; Budczies J; Winzer KJ; Dietel M; Weichert W; Denkert C
    BMC Cancer; 2013 Apr; 13():215. PubMed ID: 23627572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro.
    Freese K; Seitz T; Dietrich P; Lee SML; Thasler WE; Bosserhoff A; Hellerbrand C
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31635225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Histone Deacetylases HDAC1, HDAC2, HDAC3, and HDAC6 in Invasive Ductal Carcinomas of the Breast.
    Seo J; Min SK; Park HR; Kim DH; Kwon MJ; Kim LS; Ju YS
    J Breast Cancer; 2014 Dec; 17(4):323-31. PubMed ID: 25548579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H3K9ac and HDAC2 Activity Are Involved in the Expression of Monocarboxylate Transporter 1 in Oligodendrocyte.
    Lai Q; Du W; Wu J; Wang X; Li X; Qu X; Wu X; Dong F; Yao R; Fan H
    Front Mol Neurosci; 2017; 10():376. PubMed ID: 29184483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cells.
    Kiweler N; Brill B; Wirth M; Breuksch I; Laguna T; Dietrich C; Strand S; Schneider G; Groner B; Butter F; Heinzel T; Brenner W; Krämer OH
    Arch Toxicol; 2018 Jul; 92(7):2227-2243. PubMed ID: 29845424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Therapeutic Potential of the Novel Isotype Specific HDAC Inhibitor 4SC-202 in Urothelial Carcinoma Cell Lines.
    Pinkerneil M; Hoffmann MJ; Kohlhof H; Schulz WA; Niegisch G
    Target Oncol; 2016 Dec; 11(6):783-798. PubMed ID: 27250763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.
    Niegisch G; Knievel J; Koch A; Hader C; Fischer U; Albers P; Schulz WA
    Urol Oncol; 2013 Nov; 31(8):1770-9. PubMed ID: 22944197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy.
    Weichert W; Röske A; Gekeler V; Beckers T; Stephan C; Jung K; Fritzsche FR; Niesporek S; Denkert C; Dietel M; Kristiansen G
    Br J Cancer; 2008 Feb; 98(3):604-10. PubMed ID: 18212746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological features and prediction values of HDAC1, HDAC2, HDAC3, and HDAC11 in classical Hodgkin lymphoma.
    Huang R; Zhang X; Sophia S; Min Z; Liu X
    Anticancer Drugs; 2018 Apr; 29(4):364-370. PubMed ID: 29481474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Class I Histone Deacetylases in Ipsilateral and Contralateral Hemispheres after the Focal Photothrombotic Infarction in the Mouse Brain.
    Demyanenko S; Neginskaya M; Berezhnaya E
    Transl Stroke Res; 2018 Oct; 9(5):471-483. PubMed ID: 29218547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDAC1 and HDAC2 collectively regulate intestinal stem cell homeostasis.
    Zimberlin CD; Lancini C; Sno R; Rosekrans SL; McLean CM; Vlaming H; van den Brink GR; Bots M; Medema JP; Dannenberg JH
    FASEB J; 2015 May; 29(5):2070-80. PubMed ID: 25648995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and functional characterization of recombinant human HDAC1 and HDAC3.
    Li J; Staver MJ; Curtin ML; Holms JH; Frey RR; Edalji R; Smith R; Michaelides MR; Davidsen SK; Glaser KB
    Life Sci; 2004 Apr; 74(22):2693-705. PubMed ID: 15043985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis.
    Weichert W; Röske A; Gekeler V; Beckers T; Ebert MP; Pross M; Dietel M; Denkert C; Röcken C
    Lancet Oncol; 2008 Feb; 9(2):139-48. PubMed ID: 18207460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.